Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-12

Clinical Trial Update: Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how different antirheumatic treatments affect antibody response to vaccination with Prevenar in rheumatoid arthritis and spond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Region Skane | Conditions: Rheumatoid Arthritis, Spondylarthropathy | Phase 4 | Status: COMPLETED